Late recurrence, high-risk features, and treatment failure can signal midlife night sweats aren’t menopause, according to Cheryl Cox Kinney, MD.
|Videos|January 8, 2021
Cervical Cancer Screening: Protecting and Improving Health Outcomes of Women
Expert provides insights regarding current cervical cancer screening guidelines, in addition to the role obstetricians and gynecologists play in protecting women’s health.
Advertisement
Supported by: Hologic
Jessica Shepherd, MD, MBA
Baylor University Medical Center
Dallas, Texas
To view the publication associated with this Contemporary OB/GYN® Clinical Consult, click
Advertisement
Related to this article
Menopausal brain fog is common, and hormone therapy has neutral cognitive effects, according to Pauline M. Maki, PhD.
Distress, not low libido alone, defines HSDD, which requires a biopsychosocial evaluation, according to Holly N. Thomas, MD, MS.
Open-ended questions help ob-gyns untangle GSM and low desire and build adherence-focused treatment plans, according to Sheryl Kingsberg, PhD.
The investigational Evident test requires 3 tumor markers on the same extracellular vesicle to flag early-stage ovarian cancer.
Real-world fezolinetant (Veozah) sleep data help ob-gyns counsel patients hesitant about hormone therapy, according to Marla Shapiro, CM, MDCM.
Cultural upbringing gives context to sexual dysfunction but does not make the diagnosis, according to Sameena Rahman, MD, FACOG.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
ACOG advises against GLP-1 receptor agonists during pregnancy
2
FDA removes boxed warnings from 3 more menopausal hormone therapy products
3
Chrisandra Shufelt, MD, on cardiovascular risk assessment and menopause care
4
Chrisandra Shufelt, MD, on cardiovascular prevention at menopause
5